Search Results - "R. Kohnen"

Refine Results
  1. 1
  2. 2

    Evolution and structure of clinically relevant gene fusions in multiple myeloma by Foltz, Steven M., Gao, Qingsong, Yoon, Christopher J., Sun, Hua, Yao, Lijun, Li, Yize, Jayasinghe, Reyka G., Cao, Song, King, Justin, Kohnen, Daniel R., Fiala, Mark A., Ding, Li, Vij, Ravi

    Published in Nature communications (29-05-2020)
    “…Multiple myeloma is a plasma cell blood cancer with frequent chromosomal translocations leading to gene fusions. To determine the clinical relevance of fusion…”
    Get full text
    Journal Article
  3. 3

    Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine by Szegedi, A, Kohnen, R, Dienel, A, Kieser, M

    Published in BMJ (05-03-2005)
    “…Abstract Objective To investigate the efficacy of hypericum extract WS 5570 (St John's wort) compared with paroxetine in patients with moderate to severe major…”
    Get full text
    Journal Article
  4. 4

    Effective cabergoline treatment in idiopathic restless legs syndrome by STIASNY-KOLSTER, K, BENES, H, PEGLAU, I, HORNYAK, M, HOLINKA, B, WESSEL, K, EMSER, W, LEROUX, M, KOHNEN, R, OERTEL, W. H

    Published in Neurology (28-12-2004)
    “…To assess the efficacy and safety of the dopamine agonist cabergoline (CAB) in patients with restless legs syndrome (RLS). Patients with moderate to severe RLS…”
    Get full text
    Journal Article
  5. 5

    Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial by Trenkwalder, Claudia, Benes, Heike, Grote, Ludger, Happe, Svenja, Högl, Birgit, Mathis, Johannes, Saletu-Zyhlarz, Gerda M., Kohnen, Ralf

    Published in Movement disorders (15-04-2007)
    “…We report the first large‐scale double‐blind, randomly assigned study to compare two active dopaminergic therapies for Restless Legs Syndrome (RLS), the…”
    Get full text
    Journal Article
  6. 6

    Cognitive behavioural group therapy to improve patients’ strategies for coping with restless legs syndrome: a proof-of-concept trial by Hornyak, M, Grossmann, C, Kohnen, R, Schlatterer, M, Richter, H, Voderholzer, U, Riemann, D, Berger, M

    “…Background:Restless legs syndrome (RLS) is a usually chronic disorder accompanied by clinically relevant psychosocial impairment. To date, no psychologically…”
    Get full text
    Journal Article
  7. 7

    Efficacy and tolerability of an ulcer compression stocking for therapy of chronic venous ulcer compared with a below-knee compression bandage: results from a prospective, randomized, multicentre trial by Jünger, M., Wollina, U., Kohnen, R., Rabe, E.

    Published in Current medical research and opinion (01-10-2004)
    “…SUMMARY Objective: To investigate the possibility of improving healing rates in ulcus cruris venosum by using an ulcer compression stocking (U-Stocking)…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The prevalence and characteristics of patients with classic locked-in syndrome in Dutch nursing homes by Kohnen, R. F., Lavrijsen, J. C. M., Bor, J. H. J., Koopmans, R. T. C. M.

    Published in Journal of neurology (01-06-2013)
    “…To establish the point prevalence and characteristics of patients with locked-in syndrome (LIS), particularly of the classic type, residing in Dutch nursing…”
    Get full text
    Journal Article
  10. 10

    Efficacy of cabergoline in restless legs syndrome : A placebo-controlled study with polysomnography (CATOR) by OERTEL, W. H, BENES, H, STIASNY-KOLSTER, K, BODENSCHATZ, R, PEGLAU, I, WARMUTH, R, HAPPE, S, GEISLER, P, CASSEL, W, LEROUX, M, KOHNEN, R

    Published in Neurology (26-09-2006)
    “…To assess the efficacy and safety of the dopamine agonist cabergoline in the treatment of patients with idiopathic restless legs syndrome (CATOR study)…”
    Get full text
    Journal Article
  11. 11

    Mirtazapine compared with paroxetine in major depression by BENKERT, Otto, SZEGEDI, Armin, KOHNEN, Ralf

    Published in The Journal of clinical psychiatry (01-09-2000)
    “…The aim was to compare the efficacy and tolerability of mirtazapine with those of paroxetine. 275 outpatients with a diagnosis of major depressive episode…”
    Get full text
    Conference Proceeding Journal Article
  12. 12
  13. 13

    No augmentation during opioid treatment in restless legs syndrome – Results from a 1 year long-term trial by Kohnen, R, Bosse, B, Hopp, M, Winkelmann, J, Allen, R, Trenkwalder, C

    Published in Sleep medicine (01-12-2013)
    “…Introduction Dopaminergic treatments, the mainstay of restless legs syndrome (RLS) therapy, are often associated with augmentation (worsening of RLS symptom…”
    Get full text
    Journal Article
  14. 14

    Sleep in restless legs syndrome improves during opioid treatment – Results from a large 1-year multi-center trial by Benes, H, Trenkwalder, C, Garcia-Borreguero, D, Bosse, B, Hopp, M, Kohnen, R

    Published in Sleep medicine (01-12-2013)
    “…Introduction In severe cases of restless legs syndrome (RLS), symptoms result in bothersome impact on sleep and impairment of daytime function. This study…”
    Get full text
    Journal Article
  15. 15

    Opioid treatment is efficacious in the short- and long-term in patients with severe restless legs syndrome after failure of previous medications by Trenkwalder, C, Benes, H, Garcia-Borreguero, D, Grote, L, Hopp, M, Kohnen, R

    Published in Sleep medicine (01-12-2013)
    “…Introduction Opioids are mainstay for pain therapy and used in several countries as off-label therapy in RLS after failure of first-line therapy. This study…”
    Get full text
    Journal Article
  16. 16

    EPA-0703 – Performance of the hamilton depression rating subscales to predict antidepressant treatment response in the early course of treatment by Helmreich, I, Wagner, S, König, J, Kohnen, R, Szegedi, A, Hiemke, C, Tadic, A

    Published in European psychiatry (2014)
    “…Early improvement ( EI ), i.e. a symptom reduction from baseline of at least 20% after 2 weeks, has been proven to be a clinically useful predictor for later…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Acupuncture and Chinese herbal medicine in the treatment of patients with seasonal allergic rhinitis: a randomized‐controlled clinical trial by Brinkhaus, B., Hummelsberger, J., Kohnen, R., Seufert, J., Hempen, C.‐H., Leonhardy, H., Nögel, R., Joos, S., Hahn, E., Schuppan, D.

    Published in Allergy (Copenhagen) (01-09-2004)
    “…Background:  Patients with allergic rhinitis (AR) increasingly use complementary medicine. The aim of this study was to determine whether traditional Chinese…”
    Get full text
    Journal Article
  20. 20

    A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms by COLLADO-SEIDEL, V, KAZENWADEL, J, WETTER, T. C, KOHNEN, R, WINKELMANN, J, SELZER, R, OERTEL, W. H, TRENKWALDER, C

    Published in Neurology (15-01-1999)
    “…To investigate whether a combination treatment of regular-release levodopa (rr-L-dopa) and sustained-release levodopa (sr-L-dopa) compared with monotherapy of…”
    Get full text
    Journal Article